« Back
Home /
Carbidopa

Carbidopa

Item no.	TMO-T6795-200mg
Manufacturer	TargetMol
CASRN	28860-95-9
Amount	200 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	0,98
Citations	1. Gilbert JA. et al. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res. 2000 Nov;6(11):4365-72.
Smiles	[C@@](CC1=CC(O)=C(O)C=C1)(C(O)=O)(NN)C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	Lodosyn,(S)-(-)-Carbidopa
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Aryl Hydrocarbon Receptor\|\|\|Decarboxylase
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	226.23
Description	Carbidopa (Lodosyn) is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29±2 μM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Pathways	Metabolism\|\|\|Immunology/Inflammation\|\|\|Others
Bioactivity	Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor (IC50: 29+/-2 uM). It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA.
Receptor	aromatic-L-amino-acid decarboxylase

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6795-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question